RANDALL JOHNSON: Open Payments
NPI 1407338627 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 46 payments from 14 companies in 2025. Trend: 2023 $43 · 2024 $22 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $324 |
| Eisai Inc. | 4 | $91 |
| UCB, Inc. | 3 | $81 |
| TG Therapeutics, Inc. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| PFIZER INC. | 4 | $66 |
| SK Life Science, Inc. | 2 | $53 |
| Genentech USA, Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $48 |
| Lilly USA, LLC | 2 | $38 |
Products named: QULIPTA, UBRELVY, Leqembi, Nayzilam, BRIUMVI, KESIMPTA, NURTEC ODT, Ocrevus Zunovo.
Industry payments across MI — which companies pay providers there.
